Literature DB >> 11686099

Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation.

Z M Ruggeri1.   

Abstract

The adhesive protein von Willebrand factor mediates the initiation and progression of thrombus formation at sites of vascular injury. von Willebrand factor is synthesized in endothelial cells and megakaryocytes as a very large polymer composed of identical subunits. In the plasma, it appears as a series of multimers of regularly decreasing molecular mass, from several thousand to 500 kDa. The size of circulating von Willebrand factor multimers is controlled by proteolytic cleavage carried out by a specific protease. The biological functions of von Willebrand factor are exerted through specific domains that interact with extracellular matrix components and cell membrane receptors to promote the initial tethering and adhesion of platelets to subendothelial surfaces, as well as platelet aggregation. Moreover, von Willebrand factor binds the procoagulant co-enzyme, factor VIII, contributing to its stability and, indirectly, to its function in the generation of fibrin. This chapter presents a review of current knowledge on the structure, biosynthesis and functions of von Willebrand factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686099     DOI: 10.1053/beha.2001.0133

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  30 in total

1.  Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

Authors:  Svenja Lippok; Matthias Radtke; Tobias Obser; Lars Kleemeier; Reinhard Schneppenheim; Ulrich Budde; Roland R Netz; Joachim O Rädler
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

2.  Corynebacterium diphtheriae employs specific minor pilins to target human pharyngeal epithelial cells.

Authors:  Anjali Mandlik; Arlene Swierczynski; Asis Das; Hung Ton-That
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

3.  New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.

Authors:  Yosuke Okamura; Makoto Handa; Hidenori Suzuki; Yasuo Ikeda; Shinji Takeoka
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

Review 4.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

5.  Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions.

Authors:  M A Fallah; V Huck; V Niemeyer; A Desch; J I Angerer; T A J McKinnon; A Wixforth; S W Schneider; M F Schneider
Journal:  Biomicrofluidics       Date:  2013-08-26       Impact factor: 2.800

6.  Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

Authors: 
Journal:  P T       Date:  2010-01

Review 7.  Molecular and cellular biology of von Willebrand factor.

Authors:  Cécile V Denis
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

8.  Exponential size distribution of von Willebrand factor.

Authors:  Svenja Lippok; Tobias Obser; Jochen P Müller; Valentin K Stierle; Martin Benoit; Ulrich Budde; Reinhard Schneppenheim; Joachim O Rädler
Journal:  Biophys J       Date:  2013-09-03       Impact factor: 4.033

9.  Rational design of antithrombotic peptides to target the von Willebrand factor (vWf)--GPIb integrin interaction.

Authors:  Carlos del Carpio Munoz; William Campbell; Iren Constantinescu; Maria I C Gyongyossy-Issa
Journal:  J Mol Model       Date:  2008-10-16       Impact factor: 1.810

10.  The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.